Ventripoint Diagnostics Stock Market Value
| VPT Stock | CAD 0.16 0.01 6.67% |
| Symbol | VentriPoint |
VentriPoint Diagnostics Price To Book Ratio
VentriPoint Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to VentriPoint Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of VentriPoint Diagnostics.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in VentriPoint Diagnostics on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding VentriPoint Diagnostics or generate 0.0% return on investment in VentriPoint Diagnostics over 90 days. VentriPoint Diagnostics is related to or competes with Reliq Health. Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patien... More
VentriPoint Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure VentriPoint Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess VentriPoint Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 12.87 | |||
| Information Ratio | 0.1136 | |||
| Maximum Drawdown | 86.67 | |||
| Value At Risk | (11.11) | |||
| Potential Upside | 14.29 |
VentriPoint Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for VentriPoint Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as VentriPoint Diagnostics' standard deviation. In reality, there are many statistical measures that can use VentriPoint Diagnostics historical prices to predict the future VentriPoint Diagnostics' volatility.| Risk Adjusted Performance | 0.0947 | |||
| Jensen Alpha | 0.8904 | |||
| Total Risk Alpha | 2.9 | |||
| Sortino Ratio | 0.0952 | |||
| Treynor Ratio | (0.80) |
VentriPoint Diagnostics Backtested Returns
VentriPoint Diagnostics is out of control given 3 months investment horizon. VentriPoint Diagnostics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.13, which indicates the firm had a 0.13 % return per unit of risk over the last 3 months. We were able to interpolate twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.44% are justified by taking the suggested risk. Use VentriPoint Diagnostics Coefficient Of Variation of 987.14, semi deviation of 5.15, and Risk Adjusted Performance of 0.0947 to evaluate company specific risk that cannot be diversified away. VentriPoint Diagnostics holds a performance score of 10 on a scale of zero to a hundred. The entity has a beta of -1.35, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning VentriPoint Diagnostics are expected to decrease by larger amounts. On the other hand, during market turmoil, VentriPoint Diagnostics is expected to outperform it. Use VentriPoint Diagnostics value at risk, as well as the relationship between the skewness and day median price , to analyze future returns on VentriPoint Diagnostics.
Auto-correlation | -0.21 |
Weak reverse predictability
VentriPoint Diagnostics has weak reverse predictability. Overlapping area represents the amount of predictability between VentriPoint Diagnostics time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of VentriPoint Diagnostics price movement. The serial correlation of -0.21 indicates that over 21.0% of current VentriPoint Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.21 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
VentriPoint Diagnostics lagged returns against current returns
Autocorrelation, which is VentriPoint Diagnostics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting VentriPoint Diagnostics' stock expected returns. We can calculate the autocorrelation of VentriPoint Diagnostics returns to help us make a trade decision. For example, suppose you find that VentriPoint Diagnostics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
VentriPoint Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If VentriPoint Diagnostics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if VentriPoint Diagnostics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in VentriPoint Diagnostics stock over time.
Current vs Lagged Prices |
| Timeline |
VentriPoint Diagnostics Lagged Returns
When evaluating VentriPoint Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of VentriPoint Diagnostics stock have on its future price. VentriPoint Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, VentriPoint Diagnostics autocorrelation shows the relationship between VentriPoint Diagnostics stock current value and its past values and can show if there is a momentum factor associated with investing in VentriPoint Diagnostics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VentriPoint Stock Analysis
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.